BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15372326)

  • 1. Microtubule-associated protein tau is a substrate of ATP/Mg(2+)-dependent proteasome protease system.
    Zhang JY; Liu SJ; Li HL; Wang JZ
    J Neural Transm (Vienna); 2005 Apr; 112(4):547-55. PubMed ID: 15372326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau is not normally degraded by the proteasome.
    Feuillette S; Blard O; Lecourtois M; Frébourg T; Campion D; Dumanchin C
    J Neurosci Res; 2005 May; 80(3):400-5. PubMed ID: 15795929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SUMOylation at K340 inhibits tau degradation through deregulating its phosphorylation and ubiquitination.
    Luo HB; Xia YY; Shu XJ; Liu ZC; Feng Y; Liu XH; Yu G; Yin G; Xiong YS; Zeng K; Jiang J; Ye K; Wang XC; Wang JZ
    Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16586-91. PubMed ID: 25378699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system.
    Tai HC; Serrano-Pozo A; Hashimoto T; Frosch MP; Spires-Jones TL; Hyman BT
    Am J Pathol; 2012 Oct; 181(4):1426-35. PubMed ID: 22867711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ca2+ and Mg2+ selectively induce aggregates of PHF-tau but not normal human tau.
    Yang LS; Ksiezak-Reding H
    J Neurosci Res; 1999 Jan; 55(1):36-43. PubMed ID: 9890432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of 14-3-3z promotes tau phosphorylation at Ser262 and accelerates proteosomal degradation of synaptophysin in rat primary hippocampal neurons.
    Qureshi HY; Han D; MacDonald R; Paudel HK
    PLoS One; 2013; 8(12):e84615. PubMed ID: 24367683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Phosphorylation of tau protein].
    Uchida T; Ishiguro K
    Nihon Ronen Igakkai Zasshi; 1990 May; 27(3):280-6. PubMed ID: 2120490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteasome inhibition increases tau accumulation independent of phosphorylation.
    Liu YH; Wei W; Yin J; Liu GP; Wang Q; Cao FY; Wang JZ
    Neurobiol Aging; 2009 Dec; 30(12):1949-61. PubMed ID: 18403053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation.
    Song MS; Rauw G; Baker GB; Kar S
    Eur J Neurosci; 2008 Nov; 28(10):1989-2002. PubMed ID: 19046381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-dependent increases in tau phosphorylation in the brains of type 2 diabetic rats correlate with a reduced expression of p62.
    Jung HJ; Kim YJ; Eggert S; Chung KC; Choi KS; Park SA
    Exp Neurol; 2013 Oct; 248():441-50. PubMed ID: 23906983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tau protein degradation is catalyzed by the ATP/ubiquitin-independent 20S proteasome under normal cell conditions.
    Grune T; Botzen D; Engels M; Voss P; Kaiser B; Jung T; Grimm S; Ermak G; Davies KJ
    Arch Biochem Biophys; 2010 Aug; 500(2):181-8. PubMed ID: 20478262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites.
    Hoffmann R; Lee VM; Leight S; Varga I; Otvos L
    Biochemistry; 1997 Jul; 36(26):8114-24. PubMed ID: 9201960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tau phosphorylation on proteasome activity.
    Ren QG; Liao XM; Chen XQ; Liu GP; Wang JZ
    FEBS Lett; 2007 Apr; 581(7):1521-8. PubMed ID: 17376439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The involvement of glycogen synthase kinase-3 and protein phosphatase-2A in lactacystin-induced tau accumulation.
    Ren QG; Liao XM; Wang ZF; Qu ZS; Wang JZ
    FEBS Lett; 2006 May; 580(10):2503-11. PubMed ID: 16638578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered intracellular distribution of PrPC and impairment of proteasome activity in tau overexpressing cortical neurons.
    Canu N; Filesi I; Pristerà A; Ciotti MT; Biocca S
    J Alzheimers Dis; 2011; 27(3):603-13. PubMed ID: 21841253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotoxic mechanisms by which the USP14 inhibitor IU1 depletes ubiquitinated proteins and Tau in rat cerebral cortical neurons: Relevance to Alzheimer's disease.
    Kiprowska MJ; Stepanova A; Todaro DR; Galkin A; Haas A; Wilson SM; Figueiredo-Pereira ME
    Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1157-1170. PubMed ID: 28372990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal phosphorylation of tau proteins associated with bovine brain microtubules: activation by excess ATP and tyrosine dephosphorylation.
    Lu Q; Kanumury R; Wood JG
    J Neurosci Res; 1994 Apr; 37(6):759-68. PubMed ID: 8046776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteasome inhibition induces stress kinase dependent transport deficits--implications for Alzheimer's disease.
    Agholme L; Nath S; Domert J; Marcusson J; Kågedal K; Hallbeck M
    Mol Cell Neurosci; 2014 Jan; 58():29-39. PubMed ID: 24270002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hrd1 facilitates tau degradation and promotes neuron survival.
    Shen YX; Sun AM; Fang S; Feng LJ; Li Q; Hou HL; Liu C; Wang HP; Shen JL; Luo J; Zhou JN
    Curr Mol Med; 2012 Feb; 12(2):138-52. PubMed ID: 22280354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific Knockdown of Endogenous Tau Protein by Peptide-Directed Ubiquitin-Proteasome Degradation.
    Chu TT; Gao N; Li QQ; Chen PG; Yang XF; Chen YX; Zhao YF; Li YM
    Cell Chem Biol; 2016 Apr; 23(4):453-61. PubMed ID: 27105281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.